Drug Discovery
4 articles
How Patient-Derived Organoids Are Revolutionizing Personalized Medicine
Patient-derived organoids are revolutionizing personalized medicine by creating miniature, 3D models of human organs that mimic patient tissues. This technology accelerates drug discovery and tailors cancer treatments by predicting individual responses to therapies.
How Organs-on-Chips Recreate Human Biology for Safer Drugs
Organ-on-a-chip technology recreates human organ functions on a micro-scale using living cells and microfluidics. This platform offers a more accurate and ethical alternative for drug discovery and personalized medicine compared to traditional models.
How AI is Revolutionizing Drug Discovery and Treatment
AI-discovered molecules are achieving an 80-90% success rate in Phase I clinical trials, dramatically outperforming traditional methods and signaling a new era for drug development.
AI in early drug discovery: Advantages and challenges
AI-discovered molecules have an 80-90% success rate in Phase I clinical trials, a figure substantially higher than historic industry averages, according to PubMed and Nature .